
Beyond Cholesterol: Unveiling Other Lipids in Trans Fat-Related Heart Disease
New research from the Salk Institute suggests that sphingolipids, not just cholesterol, play a significant role in trans fat-driven cardiovascular disease. The study found that trans fats are incorporated into sphingolipids, promoting the secretion of lipoproteins that contribute to atherosclerotic plaque formation. This discovery opens new avenues for potential drug targets beyond cholesterol-lowering statins, focusing on the enzyme SPT involved in sphingolipid synthesis. The findings highlight the need for further exploration of dietary fats' impact on cardiovascular health.





